Showing results (591-600 of 936) with videos related to
Sort By:
Pageof 94
Journal of Veterinary Internal Medicine|December 16, 2010
2010 ACVIM small animal consensus statement on leptospirosis: diagnosis, epidemiology, treatment, and preventionJ E Sykes, K Hartmann, K F Lunn, et al.Proceedings of the National Academy of Sciences of the United States of America|May 19, 2006
Flows driven by flagella of multicellular organisms enhance long-range molecular transportMartin B Short, Cristian A Solari, Sujoy Ganguly, et al.Journal of the American Geriatrics Society|October 6, 2025
Latino Caregiver Experiences With Dementia Care and Healthcare NavigationLeah V Estrada, Thalia Porteny, Deanna Margius, et al.Cancers|July 29, 2023
Clinician Perspectives on Palliative Care for People with Hepatocellular Carcinoma: Facilitators of and Barriers to ReferralChristopher D Woodrell, Christie N Mulholland, Nathan E Goldstein, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 1, 1988
Inhibition of eicosanoid-mediated coronary constriction during myocardial ischemiaF R Laurindo, C K Finton, D Ezra, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 1, 1987
Phosphorylation of neurofilament proteins and chromatolysis following transection of rat sciatic nerveM E Goldstein, H S Cooper, J Bruce, et al.Clinical Chemistry|February 28, 2002
Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitusDavid B Sacks, David E Bruns, David E Goldstein, et al.Journal of Veterinary Internal Medicine|March 23, 2018
ACVIM consensus update on Lyme borreliosis in dogs and catsMeryl P Littman, Bernhard Gerber, Richard E Goldstein, et al.Journal of the Royal Society, Interface|October 16, 2009
Distribution of vaccine/antivirals and the 'least spread line' in a stratified populationE Goldstein, A Apolloni, B Lewis, et al.Biochemical Pharmacology|November 14, 2001
Inhibition of human mast cell activation with the novel selective adenosine A(2B) receptor antagonist 3-isobutyl-8-pyrrolidinoxanthine (IPDX)(2)I Feoktistov, E M Garland, A E Goldstein, et al.Pageof 94